Litigation

Recent Posts

Burg Simpson Leads National Litigation Against DePuy Orthopaedics
Posted on 2 Feb 2011 by LexisNexis Litigation Resource Community Staff

DENVER - Burg Simpson Eldredge Hersh & Jardine P.C., one of the nation's leading plaintiff litigation law firms, has announced that shareholder Seth. A. Katz has been appointed by Judge David A. Katz to serve as a member of the Plaintiffs'... Read More

Merck: The Statute Of Limitations In Securities Fraud Damage Suits
Posted on 30 Apr 2010 by Thomas O. Gorman

In a result joined by all of the justices, the Supreme Court affirmed the decision of the Third Circuit, concluding that plaintiffs' had timely filed a securities fraud suit against Merck & Co. Merck & Co. v. Reynolds , Case No. 08-905 S.Ct... Read More

Federal Vioxx Judge Awards $315.3 Million To Core Attorney Group
Posted on 20 Oct 2010 by Michael Lefkowitz

NEW ORLEANS - (Mealey's) The judge supervising the Vioxx multidistrict litigation on Oct. 19 awarded $315.3 million to the group of attorneys who conducted discovery and other work of benefit to all federal litigants and those participating in the... Read More

Merck, Canadian Plaintiffs Settle Vioxx Litigation For Up To $36.3 Million
Posted on 20 Jan 2012 by Tom Moylan

(Mealey's) Merck Sharp & Dohme Corp. and plaintiffs' counsel in four Canadian Vioxx class actions announced Jan. 19 that they have agreed to settle the litigation for up to $36.3 million ( Mignacca, et al. v. Merck Frosst Canada Ltd, et al... Read More

High Court Upholds 3rd Circuit's Ruling, Finds Stockholder's Suit Against Merck Was Timely
Posted on 27 Apr 2010 by Michael Lefkowitz

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on April 27 affirmed a Third Circuit U.S. Court of Appeals ruling that a shareholder derivative lawsuit over Merck & Co. Inc.'s marketing of Vioxx was timely and held that the statute of... Read More

Michigan Drug Shield Dooms False Claims Act Lawsuit
Posted on 18 Mar 2011 by Tom Moylan

TROY, Mich. - (Mealey's) Michigan's attempt to obtain reimbursement under its Medicaid False Claim Act (MFCA) for money spent on Vioxx was thwarted March 17 by the state's own pharmaceutical liability shield when the state's Second District... Read More

Merck Settles Charges Over Vioxx Marketing For $950M, Guilty Plea
Posted on 23 Nov 2011 by LexisNexis® Mealey's™ Legal News

BOSTON - Merck, Sharp & Dohme Inc. has agreed to plead guilty to a criminal misdemeanor and to pay $950 million to resolve criminal charges and civil claims stemming from its marketing of the painkiller Vioxx a decade ago, the U.S. Department of... Read More

Tags: FDA , Vioxx , Merck

Supreme Court Says Vioxx Lawsuit Can Proceed
Posted on 27 Apr 2010 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. – (AP) The Supreme Court said Tuesday investors who lost millions betting on the blockbuster drug Vioxx can sue Merck & Co. over whether the pharmaceutical giant provided enough information about the painkiller's risks before... Read More

Oil Spill Legal Mess Likely One Of Costliest Ever
Posted on 27 Jul 2010 by LexisNexis Litigation Resource Community Staff

MIAMI - (AP) BP PLC and the other companies involved in the Gulf of Mexico oil spill are faced with fast-multiplying lawsuits that will provoke one of the most drawn-out and costliest legal battles in U.S. history, one that could easily consume the $20... Read More

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More

Lead Attorneys In Vioxx Settlement Get $315.3M
Posted on 21 Oct 2010 by LexisNexis Litigation Resource Community Staff

NEW ORLEANS - (AP) The federal judge overseeing the thousands of lawsuits filed over withdrawn painkiller Vioxx has ruled that the lead lawyers in the case will get $315.3 million, while other lawyers who sued Merck & Co. will share $1.2 billion.... Read More

Australian Court: Vioxx Doubled Heart Attack Risk
Posted on 8 Mar 2010 by LexisNexis Litigation Resource Community Staff

SYDNEY, Australia – (AP) The once-popular painkiller Vioxx doubled the risk of heart attack and was unfit for consumption, an Australian court ruled Friday, awarding a man leading a class action suit against the drug's maker 287,000 Australian... Read More